Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130201003M |
| Application |
Cancer Marker |
The kit has been designed for the quantitative determination of Carcinoembryonic Antigen (CEA) in human serum. The method can be used for samples over the range of 1.333-1000 .000ng/ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
High-Efficiency Automated TestingAchieve rapid and accurate results with the Snibe MAGLUMI CEA (CLIA) analyzer, which processes up to 180 tests per hour. Its automatic operation, combined with batch processing and real-time functionality, ensures high productivity in busy clinical and oncology laboratories.
Integrated Quality Control and Data ManagementBenefit from built-in quality control features and advanced data storage that accommodates up to 10,000 results. The instrument integrates seamlessly with hospital and laboratory information systems via USB and LAN connections, supporting efficient workflow and data integrity.
User-Friendly and Reliable DesignDesigned for ease of use, the MAGLUMI CEA model features a touchscreen LCD for straightforward operation and an integrated barcode reader for sample management. Automated and manual maintenance modes reduce downtime, while robust construction and quiet operation make it ideal for clinical laboratory environments.
FAQ's of Snibe MAGLUMI CEA (CLIA):
Q: How does the Snibe MAGLUMI CEA (CLIA) analyzer perform quantitative detection of CEA?
A: The analyzer utilizes chemiluminescent immunoassay (CLIA) technology to measure Carcinoembryonic Antigen (CEA) levels in serum or plasma samples, delivering precise quantitative results within a measurement range of 0.2 - 100 ng/mL.
Q: What are the process steps for running a CEA test on this analyzer?
A: Users load serum or plasma samples (100 L each) into the analyzer, which automatically processes up to 180 tests per hour with an incubation time of 17 minutes. The device conducts either automated or manual maintenance as needed and stores results for up to 10,000 patients.
Q: When should the analyzer be calibrated?
A: The MAGLUMI CEA requires a 2-point calibration every 28 days or when a new reagent lot is introduced. This ensures ongoing accuracy and reliability in test results.
Q: Where can this analyzer be best utilized?
A: This equipment is optimally used in oncology, hospital, and clinical laboratory settings, particularly where high-throughput testing and reliable cancer marker screening are required.
Q: What are the main benefits of using the MAGLUMI CEA (CLIA) analyzer?
A: Key advantages include rapid detection, high sensitivity, integrated quality control, ease of operation via a touchscreen interface, robust data management, and reliable batch processing for busy laboratory environments.
Q: How should reagents and the analyzer be stored for optimal performance?
A: Reagents should be kept refrigerated at 2-8C, while the analyzer should remain at normal room temperatures (15-30C) with humidity not exceeding 85% to maintain accuracy and stability.